Language: English
Published by Cambridge University Press, 2025
ISBN 10: 1009222619 ISBN 13: 9781009222617
Seller: Books From California, Simi Valley, CA, U.S.A.
paperback. Condition: Very Good.
Language: English
Published by Cambridge University Press, 2025
ISBN 10: 1009222619 ISBN 13: 9781009222617
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Language: English
Published by Cambridge University Press, 2025
ISBN 10: 1009222619 ISBN 13: 9781009222617
Seller: California Books, Miami, FL, U.S.A.
Condition: New.
Language: English
Published by Cambridge University Press, 2025
ISBN 10: 1009222619 ISBN 13: 9781009222617
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Language: English
Published by Cambridge University Press, GB, 2025
ISBN 10: 1009222619 ISBN 13: 9781009222617
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
Paperback. Condition: New. This concise, yet authoritative, clinical reference guide fulfils the needs of diverse clinicians, pharmacists and allied health professionals prescribing for Parkinson's disease and movement disorders in contemporary clinical practice. With chapters on newly approved drugs and their effects on motor and non-motor symptoms, information is also given on their use in particular populations including the elderly and patients with cognitive impairment. Each chapter includes pharmacological/biochemical rationale for drug use, a general guide to therapeutic use, pharmacokinetics, interaction profile, adverse effects, dosing and use, special population considerations, costs and value for money considerations, clinical vignette, a summary overview, and suggested reading. Ordered alphabetically and perfect for quick reference use, the guide is practical and essential for all prescribers with responsibility for patients with Parkinson's disease, including neurologists, geriatricians, internists, neurosurgeons, psychiatrists, family physicians, pharmacists as well as allied health professionals and resident, fellow, and student trainees in all related medical fields.
Language: English
Published by Cambridge University Press, GB, 2025
ISBN 10: 1009222619 ISBN 13: 9781009222617
Seller: Rarewaves USA, OSWEGO, IL, U.S.A.
Paperback. Condition: New. This concise, yet authoritative, clinical reference guide fulfils the needs of diverse clinicians, pharmacists and allied health professionals prescribing for Parkinson's disease and movement disorders in contemporary clinical practice. With chapters on newly approved drugs and their effects on motor and non-motor symptoms, information is also given on their use in particular populations including the elderly and patients with cognitive impairment. Each chapter includes pharmacological/biochemical rationale for drug use, a general guide to therapeutic use, pharmacokinetics, interaction profile, adverse effects, dosing and use, special population considerations, costs and value for money considerations, clinical vignette, a summary overview, and suggested reading. Ordered alphabetically and perfect for quick reference use, the guide is practical and essential for all prescribers with responsibility for patients with Parkinson's disease, including neurologists, geriatricians, internists, neurosurgeons, psychiatrists, family physicians, pharmacists as well as allied health professionals and resident, fellow, and student trainees in all related medical fields.
Language: English
Published by Cambridge University Press, 2025
ISBN 10: 1009222619 ISBN 13: 9781009222617
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 55.92
Quantity: Over 20 available
Add to basketCondition: New. In.
Language: English
Published by Cambridge University Press, 2025
ISBN 10: 1009222619 ISBN 13: 9781009222617
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Language: English
Published by Cambridge University Press, 2025
ISBN 10: 1009222619 ISBN 13: 9781009222617
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition.
Language: English
Published by Cambridge University Press, 2025
ISBN 10: 1009222619 ISBN 13: 9781009222617
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New.
Language: English
Published by Cambridge University Press, GB, 2025
ISBN 10: 1009222619 ISBN 13: 9781009222617
Seller: Rarewaves USA United, OSWEGO, IL, U.S.A.
Paperback. Condition: New. This concise, yet authoritative, clinical reference guide fulfils the needs of diverse clinicians, pharmacists and allied health professionals prescribing for Parkinson's disease and movement disorders in contemporary clinical practice. With chapters on newly approved drugs and their effects on motor and non-motor symptoms, information is also given on their use in particular populations including the elderly and patients with cognitive impairment. Each chapter includes pharmacological/biochemical rationale for drug use, a general guide to therapeutic use, pharmacokinetics, interaction profile, adverse effects, dosing and use, special population considerations, costs and value for money considerations, clinical vignette, a summary overview, and suggested reading. Ordered alphabetically and perfect for quick reference use, the guide is practical and essential for all prescribers with responsibility for patients with Parkinson's disease, including neurologists, geriatricians, internists, neurosurgeons, psychiatrists, family physicians, pharmacists as well as allied health professionals and resident, fellow, and student trainees in all related medical fields.
Language: English
Published by Cambridge University Press, GB, 2025
ISBN 10: 1009222619 ISBN 13: 9781009222617
Seller: Rarewaves.com UK, London, United Kingdom
Paperback. Condition: New. This concise, yet authoritative, clinical reference guide fulfils the needs of diverse clinicians, pharmacists and allied health professionals prescribing for Parkinson's disease and movement disorders in contemporary clinical practice. With chapters on newly approved drugs and their effects on motor and non-motor symptoms, information is also given on their use in particular populations including the elderly and patients with cognitive impairment. Each chapter includes pharmacological/biochemical rationale for drug use, a general guide to therapeutic use, pharmacokinetics, interaction profile, adverse effects, dosing and use, special population considerations, costs and value for money considerations, clinical vignette, a summary overview, and suggested reading. Ordered alphabetically and perfect for quick reference use, the guide is practical and essential for all prescribers with responsibility for patients with Parkinson's disease, including neurologists, geriatricians, internists, neurosurgeons, psychiatrists, family physicians, pharmacists as well as allied health professionals and resident, fellow, and student trainees in all related medical fields.
Condition: New.
Condition: New.
Condition: New.
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.
Condition: New.
Condition: New.
Language: English
Published by Academic Press 2022-10-06, 2022
ISBN 10: 0323991734 ISBN 13: 9780323991735
Seller: Chiron Media, Wallingford, United Kingdom
Hardcover. Condition: New.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 171.77
Quantity: Over 20 available
Add to basketCondition: New. In.
Condition: As New. Unread book in perfect condition.
Condition: NEW.
Condition: As New. Unread book in perfect condition.
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
First Edition
Condition: New. 2022. 1st Edition. Hardcover. . . . . .
Language: English
Published by Elsevier Science and Technology, GB, 2022
ISBN 10: 0323991734 ISBN 13: 9780323991735
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
Hardback. Condition: New. Covid-19 and Parkinsonism, Volume 165 in the International Review in Neurobiology series, highlights new advances in the field with this new volume presenting interesting chapters that cover a variety of topics, including Parkinsonism associated with viral infections, Covid-19 and nervous system pathology: bench to bedside, Prevalence of Covid-19 in Parkinson's Disease: acute settings and hospital, Covid-19 and Parkinson's Disease: clinical features, long COVID, Smell deficits in Covid-19 and possible links with Parkinson's Disease, Spotlight on non-motor symptoms and Covid-19, and a Summary of treatment paradigms in Parkinson's Disease patients and Covid-19. Additional sections cover Covid-19 and Parkinson's Disease: nursing care, vaccination, telemedicine services, impact on advanced therapies, Covid-19-induced parkinsonism: Real life phenoconversion cases, Loneliness and impact of lockdown on Parkinson's Disease patients during the Covid-19 pandemic, Parkinson's Disease and Covid-19: Impact of ethnicity and palliative care, and more.
Condition: New. Provides the authority and expertise of leading contributors from an international board of authors Presents the latest release in the International Review of Neurobiology series Updated release includes the latest informat.
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: New. 2022. 1st Edition. Hardcover. . . . . . Books ship from the US and Ireland.
Buch. Condition: Neu. Covid-19 and Parkinsonism | K Ray Chaudhuri (u. a.) | Buch | Einband - fest (Hardcover) | Englisch | 2022 | Elsevier Inc | EAN 9780323991735 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.
Language: English
Published by Elsevier Science and Technology, GB, 2022
ISBN 10: 0323991734 ISBN 13: 9780323991735
Seller: Rarewaves.com UK, London, United Kingdom
Hardback. Condition: New. Covid-19 and Parkinsonism, Volume 165 in the International Review in Neurobiology series, highlights new advances in the field with this new volume presenting interesting chapters that cover a variety of topics, including Parkinsonism associated with viral infections, Covid-19 and nervous system pathology: bench to bedside, Prevalence of Covid-19 in Parkinson's Disease: acute settings and hospital, Covid-19 and Parkinson's Disease: clinical features, long COVID, Smell deficits in Covid-19 and possible links with Parkinson's Disease, Spotlight on non-motor symptoms and Covid-19, and a Summary of treatment paradigms in Parkinson's Disease patients and Covid-19. Additional sections cover Covid-19 and Parkinson's Disease: nursing care, vaccination, telemedicine services, impact on advanced therapies, Covid-19-induced parkinsonism: Real life phenoconversion cases, Loneliness and impact of lockdown on Parkinson's Disease patients during the Covid-19 pandemic, Parkinson's Disease and Covid-19: Impact of ethnicity and palliative care, and more.